Next earnings date: 15 Sep 2025
ImmunoPrecise Antibodies Ltd. – NASDAQ:IPA
ImmunoPrecise Antibodies Ltd. stock price today
ImmunoPrecise Antibodies Ltd. stock price monthly change
ImmunoPrecise Antibodies Ltd. stock price quarterly change
ImmunoPrecise Antibodies Ltd. stock price yearly change
ImmunoPrecise Antibodies Ltd. key metrics
Market Cap | 12.13M |
Enterprise value | 67.24M |
P/E | -3.1 |
EV/Sales | 3.31 |
EV/EBITDA | -3.30 |
Price/Sales | 4.41 |
Price/Book | 1.46 |
PEG ratio | 0.02 |
EPS | -0.79 |
Revenue | 22.68M |
EBITDA | -15.53M |
Income | -20.07M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | -128.56% |
Oper. margin | -129.52% |
Gross margin | 56.89% |
EBIT margin | -129.52% |
EBITDA margin | -68.48% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeImmunoPrecise Antibodies Ltd. stock price history
ImmunoPrecise Antibodies Ltd. stock forecast
ImmunoPrecise Antibodies Ltd. financial statements
| Apr 2023 | 5.62M | -5.12M | -91.25% |
|---|---|---|---|
| Aug 2023 | 4.68M | -9.38M | -200.06% |
| Oct 2023 | 6.15M | -2.62M | -42.63% |
| Jan 2024 | 6.22M | -2.94M | -47.26% |
| 2028 | 54.21M | 8.44M | 15.57% |
|---|
Analysts Price target
Financials & Ratios estimates
| 2024-09-16 | -0.09 | -0.11 |
|---|
| Dec 2022 | 82754000 | 21.01M | 25.39% |
|---|---|---|---|
| Aug 2023 | 79944000 | 13.70M | 17.14% |
| Oct 2023 | 75608000 | 23.57M | 31.18% |
| Jan 2024 | 78687000 | 28.86M | 36.69% |
| Apr 2023 | -2.23M | -444K | -381K |
|---|---|---|---|
| Aug 2023 | -10.31M | -89K | -152K |
| Oct 2023 | -235K | -312K | -310K |
| Jan 2024 | -666K | 57K | 613K |
ImmunoPrecise Antibodies Ltd. alternative data
| Aug 2023 | 102 |
|---|---|
| Sep 2023 | 102 |
| Oct 2023 | 102 |
| Nov 2023 | 102 |
| Dec 2023 | 102 |
| Jan 2024 | 102 |
| Feb 2024 | 102 |
| Mar 2024 | 102 |
| Apr 2024 | 102 |
| May 2024 | 102 |
| Jun 2024 | 102 |
| Jul 2024 | 102 |
ImmunoPrecise Antibodies Ltd. other data
| Quarter | Transcript |
|---|---|
| Q3 2024 14 Mar 2024 | Q3 2024 Earnings Call Transcript |
| Q2 2024 14 Dec 2023 | Q2 2024 Earnings Call Transcript |
| Q1 2024 14 Sep 2023 | Q1 2024 Earnings Call Transcript |
| Q4 2023 7 Jul 2023 | Q4 2023 Earnings Call Transcript |
-
What's the price of ImmunoPrecise Antibodies Ltd. stock today?
One share of ImmunoPrecise Antibodies Ltd. stock can currently be purchased for approximately $2.53.
-
When is ImmunoPrecise Antibodies Ltd.'s next earnings date?
ImmunoPrecise Antibodies Ltd. is estimated to report earnings on Monday, 15 Sep 2025.
-
Does ImmunoPrecise Antibodies Ltd. pay dividends?
No, ImmunoPrecise Antibodies Ltd. does not pay dividends.
-
How much money does ImmunoPrecise Antibodies Ltd. make?
ImmunoPrecise Antibodies Ltd. has a market capitalization of 12.13M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 18.65% to 24.52M US dollars. ImmunoPrecise Antibodies Ltd. made a loss 27.18M US dollars in net income (profit) last year or -$0.11 on an earnings per share basis.
-
What is ImmunoPrecise Antibodies Ltd.'s stock symbol?
ImmunoPrecise Antibodies Ltd. is traded on the NASDAQ under the ticker symbol "IPA".
-
What is ImmunoPrecise Antibodies Ltd.'s primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of ImmunoPrecise Antibodies Ltd.?
Shares of ImmunoPrecise Antibodies Ltd. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does ImmunoPrecise Antibodies Ltd. have?
As Jul 2024, ImmunoPrecise Antibodies Ltd. employs 102 workers.
-
When ImmunoPrecise Antibodies Ltd. went public?
ImmunoPrecise Antibodies Ltd. is publicly traded company for more then 23 years since IPO on 7 Jan 2002.
-
What is ImmunoPrecise Antibodies Ltd.'s official website?
The official website for ImmunoPrecise Antibodies Ltd. is ipatherapeutics.com.
-
Where are ImmunoPrecise Antibodies Ltd.'s headquarters?
ImmunoPrecise Antibodies Ltd. is headquartered at 3204–4464 Markham Street, Victoria, BC.
-
How can i contact ImmunoPrecise Antibodies Ltd.?
ImmunoPrecise Antibodies Ltd.'s mailing address is 3204–4464 Markham Street, Victoria, BC and company can be reached via phone at +250 4830308.
ImmunoPrecise Antibodies Ltd. company profile:
ImmunoPrecise Antibodies Ltd.
ipatherapeutics.comNASDAQ
72
Biotechnology
Healthcare
ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research purposes. Its contract research organization services include custom antigen modeling, design, and manufacturing; B cell sorting, screening, and sequencing; custom, immune, and naive phage display production and screening; transgenic animals and multi-species antibody discovery; bi-specific, tri-specific, VHH, and VNAR (shark) antibody manufacturing; DNA cloning, protein and antibody downstream processing; antibody characterization on label-free biosensors and antibody engineering; transient and stable cell line generation; antibody optimization and humanization; hybridoma production with multiplexed, high-throughput screening, and clone-picking; and cryopreservation. The company has research collaboration agreements with Pierre Fabre S.A for antibody discovery; and Elektrofi, Inc. to explore a high-concentration formulation of COVID-19 antibody cocktail, PolyTope TATX-03. ImmunoPrecise Antibodies Ltd. was incorporated in 1983 and is based in Victoria, Canada.
Victoria, BC V8Z 7X8
CIK: 0001715925
ISIN: CA45257F2008
CUSIP: 45257F200
